CA3009734C — Ointment comprising an oxazole compound
Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2025-07-08 · 1y expired
What this patent protects
The present invention relates to an ointment. This ointment stably comprises an oxazole compound that exhibits specific inhibitory activity against PDE4 and is represented by formula (11). This ointment can be effectively absorbed through the skin.
USPTO Abstract
The present invention relates to an ointment. This ointment stably comprises an oxazole compound that exhibits specific inhibitory activity against PDE4 and is represented by formula (11). This ointment can be effectively absorbed through the skin.
Drugs covered by this patent
- Moizerto (DIFAMILAST) · OTSUKA PHARMACEUTICAL Co., Ltd
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.